What is Required to Gain Approval of Lipid Altering Drugs?

  • Solomon Sobel
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 100)

Abstract

In practical terms, there really are two questions:
  1. A.

    How does one achieve approval for a drug for even the most limited indication? and

     
  2. B.

    How does one get approval for the indication of preventing coronary heart disease?

     

Keywords

Cholesterol Pancreatitis Marketing Triglyceride 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • Solomon Sobel

There are no affiliations available

Personalised recommendations